ALLIANCEBERNSTEIN L.P. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$720,468
-18.8%
132,1960.0%0.00%
Q2 2023$887,035
-24.0%
132,1960.0%0.00%
-100.0%
Q1 2023$1,167,291
+15.6%
132,1960.0%0.00%
Q4 2022$1,009,977
+7.3%
132,1960.0%0.00%
Q3 2022$941,000
-16.2%
132,196
-4.8%
0.00%
-100.0%
Q2 2022$1,123,000
+85.6%
138,821
+218.7%
0.00%
Q1 2022$605,000
-51.8%
43,554
-2.5%
0.00%
Q4 2021$1,254,000
-24.0%
44,687
-7.9%
0.00%
-100.0%
Q3 2021$1,650,000
-18.2%
48,536
-1.7%
0.00%0.0%
Q2 2021$2,018,000
+16.4%
49,398
+14.7%
0.00%0.0%
Q1 2021$1,734,000
-31.2%
43,063
+1.0%
0.00%0.0%
Q4 2020$2,522,000
+36.5%
42,651
+12.2%
0.00%0.0%
Q3 2020$1,848,000
+13.2%
38,001
+12.6%
0.00%0.0%
Q2 2020$1,633,000
+97.2%
33,751
+13.2%
0.00%0.0%
Q1 2020$828,000
+6.0%
29,821
+14.3%
0.00%
Q4 2019$781,000
+77.9%
26,091
+83.7%
0.00%
Q3 2019$439,000
-87.9%
14,201
-81.1%
0.00%
-100.0%
Q2 2019$3,623,00075,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders